The “black swan” virus
One month ago, markets finally took note of COVID-19 and its critical impact on the global economy. Our Healthcare Investment Team recently published a “Thoughts from the street” piece that provides more details about SARSCoV- 2 treatment developments.
Intense R&D efforts will help us manage and eventually treat the virus. In the meantime, assessing the impact of government containment measures and stimulus packages on the global economy continues to be challenging.
Going back more than 20 years, Kieger’s legacy has been built in healthcare and small companies. Over these decades we have developed our own “unique” asset allocation which has some outstanding and attractive portfolio characteristics, especially in recent turbulent times.
Recent developments suggest that the spread of the virus might continue around the world before we see some positive newsflow resulting from quarantine measures put in place.